Citation: Yuantao Mao, Wen Zhang, Xinru Qi, Chuanchen Wu, Xin Wang, Ping Li, Bo Tang. Dual-channel and HSCs-targeted fluorescent nanoprobes illuminate the COX-2-O₂^•−/NO-Pten axis driving fibrosis-induced hepatocellular carcinoma immune evasion[J]. Chinese Chemical Letters, ;2026, 37(12): 112314. doi: 10.1016/j.cclet.2025.112314 shu

Dual-channel and HSCs-targeted fluorescent nanoprobes illuminate the COX-2-O₂^•−/NO-Pten axis driving fibrosis-induced hepatocellular carcinoma immune evasion

Yuantao Mao ^a ,
Wen Zhang ^{a, *,} ,
Xinru Qi ^a ,
Chuanchen Wu ^d ,
Xin Wang ^a ,
Ping Li ^{a, b, *,} ,
Bo Tang ^{a, c}

a.
College of Chemistry, Chemical Engineering, and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institutes of Biomedical Sciences, Shandong Normal University, Ji'nan 250014, China
b.
College of Chemistry and Chemical Engineering, Key Laboratory of Water Security and Water Environment Protection in Plateau Intersection, Ministry of Education, Northwest Normal University, Lanzhou 730070, China
c.
Laoshan Laboratory, Qingdao 266237, China
d.
College of Medicine, Linyi University, Linyi 276000, China

zhangwen@sdnu.edu.cn

lip@sdnu.edu.cn

Received Date: 2 September 2025
Revised Date: 18 December 2025
Accepted Date: 22 December 2025
Available Online: 23 December 2025

Figures(4)

Hepatic fibrosis (HF) is critical for immune evasion in hepatocellular carcinoma (HCC), mainly driven by hepatic stellate cell (HSCs) activation, though the underlying molecular mechanisms linking HSCs activation to immune evasion remain unclear. Here, we report a targeted fluorescent nanoprobe platform for visualizing and dissecting oxidative stress dynamics driving HCC immune evasion in fibrotic tumor microenvironments. We develop a dual-channel fluorescent probe (FP-CP) enabling crosstalk-free detection of superoxide anion (O₂^•−) and nitric oxide (NO) with high sensitivity and spectral separation. To achieve HSCs-specific targeting, FP-CP is encapsulated into nanoparticles surface-functionalized with the HSCs-targeting peptide HTP, yielding HTP-FP-CP nanoprobes that selectively accumulate in fibrotic niches. Using this nanoplatform, in situ imaging reveals coordinated O₂^•−/NO elevation during HSCs activation, directly linked to oxidative inactivation of the tumor suppressor phosphatase and tensin homolog (Pten). Mechanistically, cyclooxygenase-2 (COX-2) elevation drives O₂^•−/NO accumulation, with O₂^•− and their products peroxynitrite (ONOO⁻) directly oxidizing/nitrifying residues in Pten. This oxidative-mediated Pten suppression activates the protein kinase B (AKT)- mammalian target of rapamycin (mTOR)-programmed cell death ligand 1 (PD-L1) axis, facilitating HCC immune evasion. Our study identifies the COX-2-O₂^•−/NO-Pten-Akt-mTOR-PD-L1 pathway as a critical oxidative stress-mediated molecular bridge between HF and HCC, and establishes HTP-FP-CP as a powerful nanoplatform for probing these oxidative stress dynamics in vivo, providing insights into potential therapeutic strategies for intercepting HCC in fibrotic patients.
- Antitumor agents,
- Nanoparticles,
- 6-Aminonicotinamide,
- Disulfidptosis,
- Ovarian cancer therapy
1. [1]
  A. Vogel, T. Meyer, G. Sapisochin, et al., Lancet 400 (2022) 1345–1362. doi: 10.1016/S0140-6736(22)01200-4
2. [2]
  A.J. Craig, J. von Felden, T. Garcia-Lezana, et al., Nat. Rev. Gastro. Hepat. 17 (2022) 139–152.
3. [3]
  M. Maluccio, A. Covey, CA Cancer J. Clin. 62 (2012) 394–399. doi: 10.3322/caac.21161
4. [4]
  Y.Y. Du, S.S. Wu, et al., Adv. Sci. 11 (2024) e2404756. doi: 10.1002/advs.202404756
5. [5]
  U. Harjes, Nat. Rev. Cancer 17 (2017) 453.
6. [6]
  P.H.D. Nguyen, S. Ma, C.Z.J. Phua, et al., Nat. Commun. 12 (2021) 227. doi: 10.1038/s41467-020-20171-7
7. [7]
  S. Affo, A. Nair, F. Brundu, et al., Cancer Cell 39 (2021) 866–882. doi: 10.1016/j.ccell.2021.03.012
8. [8]
  T. Higashi, S.L. Friedman, Y. Hoshida, Adv. Drug Deliv. Rev. 121 (2017) 27–42. doi: 10.1016/j.addr.2017.05.007
9. [9]
  J.H. Lee, K.H. Seo, J.H. Yang, et al., Free Radic. Biol. Med. 225 (2024) 181–192. doi: 10.1016/j.freeradbiomed.2024.10.259
10. [10]
  H. Rho, A.R. Terry, C. Chronis, N. Hay, Cell Metab. 35 (2023) 1406–1423. doi: 10.1016/j.cmet.2023.06.013
11. [11]
  S. Khanal, Y. Liu, A.O. Bamidele, et al., Sci. Adv. 10 (2024) eadn5228. doi: 10.1126/sciadv.adn5228
12. [12]
  L.X. Yang, C. Qi, S. Lu, et al., Nat. Commun. 16 (2025) 524.
13. [13]
  V. Hernandez-Gea, S.L. Friedman, Annu. Rev. Pathol. 6 (2011) 425–456. doi: 10.1146/annurev-pathol-011110-130246
14. [14]
  J.M. Jeong, S.E. Choi, Y.R. Shim, et al., Hepatology 16 (2024) 134–156. doi: 10.1177/15554589241288900
15. [15]
  D.P. Sun, W. Li, D.Y. Ding, et al., Cell Death Discov. 10 (2024) 230. doi: 10.1038/s41420-024-01995-4
16. [16]
  M.Y. Ke, T. Xu, Y. Fang, et al., Cancer Lett. 513 (2021) 14–25. doi: 10.1016/j.canlet.2021.05.007
17. [17]
  X. Yang, Q. Li, W. Liu, et al., Cell. Mol. Immunol. 20 (2023) 583–599. doi: 10.1038/s41423-023-00983-5
18. [18]
  S. Wang, W.X. Ren, J.T. Hou, et al., Chem. Soc. Rev. 50 (2021) 8887–8902. doi: 10.1039/d1cs00083g
19. [19]
  J. Zhang, Q.H. Yu, W.Y. Chen, J. Fluoresc. 35 (2025) 2497–2509.
20. [20]
  X. Wang, X. Zhou, Z. Zhang, et al., J. Mater. Chem. B 13 (2025) 3677–3684. doi: 10.1039/d4tb02711f
21. [21]
  Y. Chen, Nitric Oxide 98 (2020) 1–19.
22. [22]
  L.L. Wu, J.H. Liu, X. Tian, et al., J. Am. Chem. Soc. 144 (2022) 174–183. doi: 10.1021/jacs.1c07954
23. [23]
  Z.X. Chen, Q. Li, Y. Wu, J. Song, et al., Nat. Commun. 16 (2025) 238. doi: 10.1038/s41467-024-55503-4
24. [24]
  H. Xiao, W. Zhang, P. Li, et al., Angew. Chem. Int. Ed. 59 (2020) 4216–4230. doi: 10.1002/anie.201906793
25. [25]
  G. Gan, T. Ma, G. Zhang, K. He, J. Hu, TrAC-Trends Anal. Chem. 168 (2023) 117340. doi: 10.1016/j.trac.2023.117340
26. [26]
  C. Chen, H. Gao, H. Ou, et al., J. Am. Chem. Soc. 144 (2022) 3429–3441. doi: 10.1021/jacs.1c11455
27. [27]
  Y. Shen, W. Li, Z. Zhou, et al., Angew. Chem. Int. Ed. 63 (2024) e202406332. doi: 10.1002/anie.202406332
28. [28]
  Y.Y. Zhao, Y. Xu, X. Zhang, et al., Angew. Chem. Int. Ed. 63 (2025) e202506412.
29. [29]
  L. Zhu, Y. Pan, Z. Hua, et al., J. Am. Chem. Soc. 146 (2024) 14307–14317. doi: 10.1021/jacs.4c04036
30. [30]
  L. Wang, R. Leite de Oliveira, S. Huijberts, et al., Cell 173 (2018) 1413–1425. doi: 10.1016/j.cell.2018.04.012
31. [31]
  S. Chakrabarti, S.S. Visweswariah, Cell Rep. 33 (2020) 108368. doi: 10.1016/j.celrep.2020.108368
32. [32]
  Z. Huang, L. Zhou, J.F. Duan, et al., Adv. Sci. 11 (2024) e2306929. doi: 10.1002/advs.202306929
33. [33]
  X.Z. Yuan, Y. Qin, H.C. Zhang, et al., Chin. Chem. Lett. 36 (2025) 1170715. doi: 10.1016/j.cclet.2024.110715
34. [34]
  M.R. Zhang, L.Y. Jin, Y.D. Zhu, et al., Chin. Chem. Lett. 36 (2025) 110772. doi: 10.1016/j.cclet.2024.110772
35. [35]
  Y.L. Yang, J.Y. Zhang, Y. Wang, et al., Chin. Chem. Lett. 36 (2025) 110834. doi: 10.1016/j.cclet.2025.110834
36. [36]
  W. Zhang, P. Li, F. Yang, et al., J. Am. Chem. Soc. 135 (2013) 14956–14959. doi: 10.1021/ja408524j
37. [37]
  T.T. Han, Y. Sun, C. Zhao, et al., J. Med. Chem. 67 (2024) 4026–4035. doi: 10.1021/acs.jmedchem.3c02344
38. [38]
  P. Huang, L. Feng, E.A. Oldham, et al., Nature 407 (2000) 390–395. doi: 10.1038/35030140
39. [39]
  Y. Fang, X.H. Hu, Z.G. Jia, et al., Australas. J. Dermatol. 53 (2012) 172–180. doi: 10.1111/j.1440-0960.2012.00912.x
40. [40]
  Z.L. Zhao, S.C. Kim, Y. Jiao, et al., Behav. Neurol. 2021 (2021) 2149371.
41. [41]
  X.K. Zhao, L. Yu, M.L. Cheng, et al., Sci. Rep. 7 (2017) 4032. doi: 10.1038/s41598-017-04317-0
42. [42]
  Q.S. Liao, J.Y. Xu, B.G. Tuo, R. Xie, Gastroenterology 158 (2020) S1276.
43. [43]
  J. Nemunaitis, S.J. Vukelja, D. Richards, C. Cunningham, Cancer Invest. 24 (2006) 553–561. doi: 10.1080/07357900600894732
44. [44]
  E.K. Yim, G. Peng, H. Dai, et al., Cancer Cell 15 (2009) 304–314. doi: 10.1016/j.ccr.2009.02.012
45. [45]
  P. Xie, Z.Q. Peng, Y.J. Chen, et al., Cell Res. 31 (2021) 291–311. doi: 10.1038/s41422-020-00443-z
46. [46]
  T. Jamaspishvili, D.M. Berman, A.E. Ross, H.I. Scher, et al., Nat. Rev. Urol. 15 (2018) 222–234. doi: 10.1038/nrurol.2018.9
47. [47]
  G.R. Masson, R.L. Williams, CSH Perspect. Med. 10 (2020) a036152. doi: 10.1101/cshperspect.a036152
48. [48]
  W.J. Wu, C. Zhang, T.W. Rees, et al., Anal. Chem. 92 (2020) 6003–6009. doi: 10.1021/acs.analchem.0c00259
49. [49]
  H. Yang, X.F. Yang, S.D. Wu, J.H. Xiao, Clin. Chim. Acta 506 (2020) 196–203. doi: 10.1016/j.cca.2020.03.024
50. [50]
  E. Efsen, A. Bonacchi, S. Pastacaldi, et al., Hepatology 33 (2001) 713–721. doi: 10.1053/jhep.2001.22761
51. [51]
  E. Courtois, M. Marques, A. Barrientos, et al., J. Am. Soc. Nephrol. 14 (2003) 1464–1470. doi: 10.1097/01.ASN.0000064947.14997.69
52. [52]
  J.J. Teixeira-da-Silva, H.S. Nunes-Moreira, C.O. Silva, et al., Life Sci. 225 (2019) 29–38. doi: 10.1016/j.lfs.2019.03.074
53. [53]
  A. Glaviano, A.S.C. Foo, H.Y. Lam, et al., Mol. Cancer 22 (2023) 138. doi: 10.1186/s12943-023-01827-6
1. [1]
  Nannan Fan , Zhen Zhang , Huiyan Zu , Xinkui Liu , Bin Wang , Xiuming Miao , Chu Chu , Yunhong Zhang , Xiaoxiao Zhu , Ping Li , Xia Li . Targeting disulfidptosis for ovarian cancer therapy induced by nanodrugs carrying 6-aminonicotinamide. Chinese Chemical Letters, 2026, 37(8): 111812-. doi: 10.1016/j.cclet.2025.111812
2. [2]
  Shangqian Zhang , Jiaxuan Li , Xuan Hu , Zelong Chen , Junliang Dong , Chenhao Hu , Shuang Chao , Yinghua Lv , Yuxin Pei , Zhichao Pei . H₂S and NIR light-driven nanomotors induce disulfidptosis for targeted anticancer therapy by enhancing disruption of tumor metabolic symbiosis. Chinese Chemical Letters, 2025, 36(1): 110314-. doi: 10.1016/j.cclet.2024.110314
3. [3]
  Zhiyuan Huang , Fangqiu Fu , Chaoqiang Deng , Shiyang Wu , Mingxuan Huang , Xianyi Sha , Ming Q Wei , Zhiwen Zhang , Yang Zhang . Strategies of designing lymph nodes-targeting nanoparticles for cancer immunotherapy. Chinese Chemical Letters, 2026, 37(9): 111993-. doi: 10.1016/j.cclet.2025.111993
4. [4]
  Bohan Chen , Liming Gong , Jing Feng , Mingji Jin , Liqing Chen , Zhonggao Gao , Wei Huang . Research advances of nanoparticles for CAR-T therapy in solid tumors. Chinese Chemical Letters, 2024, 35(9): 109432-. doi: 10.1016/j.cclet.2023.109432
5. [5]
  Wei Su , Xiaoyan Luo , Peiyuan Li , Ying Zhang , Chenxiang Lin , Kang Wang , Jianzhuang Jiang . Phthalocyanine self-assembled nanoparticles for type Ⅰ photodynamic antibacterial therapy. Chinese Chemical Letters, 2024, 35(12): 109522-. doi: 10.1016/j.cclet.2024.109522
6. [6]
  Yiran Tao , Chunlei Dai , Zhaoxiang Xie , Xinru You , Kaiwen Li , Jun Wu , Hai Huang . Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer. Chinese Chemical Letters, 2024, 35(8): 109170-. doi: 10.1016/j.cclet.2023.109170
7. [7]
  Lian Jin , Juan Zhang , Libo Nie , Yan Deng , Ghulam Jilany Khana , Nongyue He . Chitosan nanoparticles act as promising carriers of microRNAs to brain cells in neurodegenerative diseases. Chinese Chemical Letters, 2025, 36(10): 110774-. doi: 10.1016/j.cclet.2024.110774
8. [8]
  Yuwen Zhu , Xiang Deng , Yan Wu , Baode Shen , Lingyu Hang , Yuye Xue , Hailong Yuan . Formation mechanism of herpetrione self-assembled nanoparticles based on pH-driven method. Chinese Chemical Letters, 2025, 36(1): 109733-. doi: 10.1016/j.cclet.2024.109733
9. [9]
  Mengdie Li , Shundong Cai , Hongjin Li , Yuhang Cheng , Jinfa Ye , Lang Ke , Yun Han , Min Su , Gang Liu , Chengchao Chu . Nanotherapeutics for ocular posterior segment diseases therapy: Towards its advances and challenges. Chinese Chemical Letters, 2026, 37(5): 111392-. doi: 10.1016/j.cclet.2025.111392
10. [10]
  Yihao Zhang , Yang Jiao , Xianchao Jia , Qiaojia Guo , Chunying Duan . Highly effective self-assembled porphyrin MOCs nanomaterials for enhanced photodynamic therapy in tumor. Chinese Chemical Letters, 2024, 35(5): 108748-. doi: 10.1016/j.cclet.2023.108748
11. [11]
  Tianxia Chen , Yunhui Chen , Weiwei Li , Peipei Cen , Yan Guo , Jin Zhang , Cunding Kong , Xiangyu Liu . Fabricating AuAg-nanoparticles/ZIF-8 composites for selective detection and efficient extraction of dinitroaniline pesticides. Chinese Chemical Letters, 2025, 36(8): 110214-. doi: 10.1016/j.cclet.2024.110214
12. [12]
  Zhongxin Duan , Yue Wang , Yunchu Zhang , Xia Liu , Wanyu Wang , Hua Li , Qingyang Lu , Chao You , Yongzhong Cheng , Cong Wu , Xiang Gao . Intranasal pterostilbene nanoparticles delivery alleviates neuroinflammation and brain injury after intracerebral hemorrhage. Chinese Chemical Letters, 2026, 37(5): 111248-. doi: 10.1016/j.cclet.2025.111248
13. [13]
  Yue Wang , Zhongxin Duan , Huabin Zhang , Xia Liu , Qingyang Lu , Hua Li , Yunchu Zhang , Jiaqi Zheng , Wenyi Zhan , Mingze Du , Xifeng Zhang , Xiang Gao , Yunxiang Ji . Intranasal delivery of rosiglitazone-loaded chitosan nanoparticles promotes erythrocyte phagocytosis and alleviates brain injury after intracerebral hemorrhage. Chinese Chemical Letters, 2026, 37(12): 112336-. doi: 10.1016/j.cclet.2025.112336
14. [14]
  Yixin Zhang , Ting Wang , Jixiang Zhang , Pengyu Lu , Neng Shi , Liqiang Zhang , Weiran Zhu , Nongyue He . Formation mechanism for stable system of nanoparticle/protein corona and phospholipid membrane. Chinese Chemical Letters, 2024, 35(4): 108619-. doi: 10.1016/j.cclet.2023.108619
15. [15]
  Keyang Li , Yanan Wang , Yatao Xu , Guohua Shi , Sixian Wei , Xue Zhang , Baomei Zhang , Qiang Jia , Huanhua Xu , Liangmin Yu , Jun Wu , Zhiyu He . Flash nanocomplexation (FNC): A new microvolume mixing method for nanomedicine formulation. Chinese Chemical Letters, 2024, 35(10): 109511-. doi: 10.1016/j.cclet.2024.109511
16. [16]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
17. [17]
  Fereshte Hassanzadeh-Afruzi , Mina Azizi , Iman Zare , Ehsan Nazarzadeh Zare , Anwarul Hasan , Siavash Iravani , Pooyan Makvandi , Yi Xu . Advanced metal-organic frameworks-polymer platforms for accelerated dermal wound healing. Chinese Chemical Letters, 2024, 35(11): 109564-. doi: 10.1016/j.cclet.2024.109564
18. [18]
  Shenglan Zhou , Haijian Li , Hongyi Gao , Ang Li , Tian Li , Shanshan Cheng , Jingjing Wang , Jitti Kasemchainan , Jianhua Yi , Fengqi Zhao , Wengang Qu . Recent advances in metal-loaded MOFs photocatalysts: From single atom, cluster to nanoparticle. Chinese Chemical Letters, 2025, 36(1): 110142-. doi: 10.1016/j.cclet.2024.110142
19. [19]
  Liangyu Zhang , Lei Lei , Zhuangzhuang Zhao , Guizhi Yang , Kaitao Wang , Liying Wang , Ningxin Zhang , Yanjia Ai , Xinqing Ma , Guannan Liu , Meng Zhao , Jun Wu , Dongjun Lin , Chun Chen . Enhanced venetoclax delivery using l-phenylalanine nanocarriers in acute myeloid leukemia treatment. Chinese Chemical Letters, 2025, 36(6): 110316-. doi: 10.1016/j.cclet.2024.110316
20. [20]
  Sameena Noor Khattak , Kodzo Prosper Adzavon , Weijian Zhao , Wang Sheng . Advances in neoantigen peptide-based nanovaccines for targeted tumor immunotherapy: Multifaceted strategies, challenges, and future perspectives. Chinese Chemical Letters, 2026, 37(11): 112244-. doi: 10.1016/j.cclet.2025.112244

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(15)
HTML views(0)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Dual-channel and HSCs-targeted fluorescent nanoprobes illuminate the COX-2-O2•−/NO-Pten axis driving fibrosis-induced hepatocellular carcinoma immune evasion

Metrics

通讯作者: 陈斌, bchen63@163.com

Dual-channel and HSCs-targeted fluorescent nanoprobes illuminate the COX-2-O₂^•−/NO-Pten axis driving fibrosis-induced hepatocellular carcinoma immune evasion